AstraZeneca reported 1.4B in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Alcon AG ALC:SW 254M 34M
Amgen AMGN:US $ 2333M 204M
AstraZeneca AZN:LN 1.4B 366M
Astrazeneca AZN:US 1.4B 366M
AstraZeneca AZN:SS 1.4B 366M
Bayer BAYN:GR 1.64B 1.42B
Biogen BIIB:US $ 1030.1M 12.3M
Bristol Myers Squibb BMY:US $ 2967M 411M
Eli Lilly And LLY:US $ 1428.4M 237.8M
Fresenius FRE:GR 1.04B 29M
Fresenius Medical Care FME:GR 402M 44M
Galapagos GLPG:NA -46750000 4.05M
Genmab GEN:DC 787M 255M
Gilead Sciences GILD:US $ 2262M 639M
GlaxoSmithKline GSK:LN 1.96B 281M
GRIFOLS GRF:SM 245.2M 40.86M
H. Lundbeck A/S LUN:DC 596M 286M
Hikma Pharmaceutical HIK:LN 280M 2M
Lonza Group LONN:SW 599M 271M
Merck MRK:GR 1.16B 63M
Merk MRK:US $ 3930M 332M
Novartis NOVN:VX 3.4B 415M
Orion ORNBV:FH 71M 4M
Pfizer PFE:US $ 6662M 905M
Philips PHIA:NA 444M 140M
Recordati REC:IM 126.04M 381K
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M